» Articles » PMID: 29142225

Comparative Genomic Analysis of Esophageal Squamous Cell Carcinoma Between Asian and Caucasian Patient Populations

Abstract

Esophageal squamous cell carcinoma is a major histological type of esophageal cancer, with distinct incidence and survival patterns among races. Although previous studies have characterized somatic mutations in this disease, a rigorous comparison between different patient populations has not been conducted. Here we sequence the samples of 316 Chinese patients, combine them with those from The Cancer Genome Atlas, and perform a comparative analysis between Asian and Caucasian patients. We find that mutated CSMD3 is associated with better prognosis in Asian patients. Applying a robust computational strategy that adjusts for both technical and biological confounding factors, we find that TP53, EP300, and NFE2L2 show higher mutational frequencies in Asian patients. Moreover, NFE2L2 mutations correlate with the allele status of a nearby high-Fst SNP, suggesting their potential interaction. Our study provides insights into the molecular basis underlying the striking racial disparities of this disease, and represents a general computational framework for such a cross-population comparison.

Citing Articles

Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study.

Zhu J, Du L, Li H, Ran X, Zeng H, Wei W J Natl Cancer Cent. 2024; 4(4):318-325.

PMID: 39735444 PMC: 11674431. DOI: 10.1016/j.jncc.2024.04.001.


Metabolic Chaos in Kidney Disease: Unraveling Energy Dysregulation.

Gupta P, Zhu S, Gui Y, Zhou D J Clin Med. 2024; 13(22).

PMID: 39597916 PMC: 11594442. DOI: 10.3390/jcm13226772.


Esophageal squamous cell carcinoma in a patient with mutation: a rare association.

Naviwala M, Samar M, Shoaib D, Akbar F, Idrees R, Rashid Y Ecancermedicalscience. 2024; 18:1730.

PMID: 39421182 PMC: 11484678. DOI: 10.3332/ecancer.2024.1730.


The Japanese Esophageal Society classification for prediction of superficial esophageal squamous cell neoplasia invasion depth: Validation in a Western population.

Beaufort I, Zuithoff N, Brosens L, Furukawa K, Goto O, Koch A United European Gastroenterol J. 2024; 12(8):1069-1080.

PMID: 39031730 PMC: 11485661. DOI: 10.1002/ueg2.12601.


[ infection facilitates immune escape of esophageal cancer by enhancing YTHDF2-mediated Fas degradation].

Yang Z, Zhang X, Liu Y, Zhang J, Yuan X Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(6):1159-1165.

PMID: 38977346 PMC: 11237310. DOI: 10.12122/j.issn.1673-4254.2024.06.17.


References
1.
. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017; 541(7636):169-175. PMC: 5651175. DOI: 10.1038/nature20805. View

2.
Radenbaugh A, Ma S, Ewing A, Stuart J, Collisson E, Zhu J . RADIA: RNA and DNA integrated analysis for somatic mutation detection. PLoS One. 2014; 9(11):e111516. PMC: 4236012. DOI: 10.1371/journal.pone.0111516. View

3.
Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

4.
Taioli E, Wolf A, Camacho-Rivera M, Kaufman A, Lee D, Bhora F . Racial disparities in esophageal cancer survival after surgery. J Surg Oncol. 2016; 113(6):659-64. DOI: 10.1002/jso.24203. View

5.
Holsinger K, Weir B . Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet. 2009; 10(9):639-50. PMC: 4687486. DOI: 10.1038/nrg2611. View